Prostate Cancer (Screening)
"Longitudinal Screening for Prostate Cancer with Prostate-Specific Antigen."
Published in Cancer Weekly, November 25th, 1996
According to the authors' abstract of an article published in JAMA - Journal of the American Medical Association, "Objective: To determine for the first 4 years of serial prostate-specific antigen (PSA)-based screening trends in compliance, prevalence of abnormal screening test results, cancer detection rates, and stage and grade of cancers detected. Setting: A community-based study of serial screening for prostate cancer with serum PSA measurements. Setting: University medical center. Subjects: A total of 10 248 male volunteers at least 50 years old who were screened at 6-month intervals for a minimum of 48 months. Main Outcome Measures: ...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1996-11-25)
More Articles from Cancer Weekly
- Tumorigenesis (HBV)
HBx Displays Weak Link to Tumors - Antisense Technology (Genetics)
Technology Used in Correcting Gene Function Inside Cell Nucleus - Brain Cancer (Angiogenesis)
Thalidomide Clinical Trials Expanded To Treat Cancer - Breast Cancer
Indigent Women with Cancer Offered Reconstruction Infrequently - Breast Cancer (Genetics)
Genetics: Why Some Women Smokers Develop Cancer and Others Don't - Breast Cancer (Therapy)
Innovative Laser Therapy as a Potential Alternative To Lumpectomy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
